Charleston founders have a useful local set, but the investors enter at different moments. IAG describes leading across several venture stages, Alerion looks for initial commercial traction, and Good Growth specializes in science and technology. This guide adds South Carolina and wider Southeast routes without turning every regional fund into a Charleston office.
Compare 16 investment routes by connection, stage and sector, then use the worked example and copyable worksheet to build a more useful first research wave.
Choose a Charleston shortlist by traction and technology
| Your situation | Research first | Prepare or clarify |
|---|---|---|
| B2B software with initial customer revenue | Alerion, Cofounders, Valor and matching seed firms | Show customer use and capital-efficient growth potential. |
| Scientific or hardtech development | Good Growth, Oval Park, relevant Hatteras strategy | Prepare the technical milestone and commercialization evidence. |
| South Carolina company building a financing round | SC Launch, VentureSouth, stage-matched IAG research | Review state conditions, network screening and the needed round role. |
Pick a small first wave you can research well. For every candidate, save one source-backed reason for fit and one question to resolve. Prioritize the firms that fit the company you have today, not the stage you hope to reach next year.
Compare 16 investor routes
This is an unranked, selective list of investment organizations and clearly identified investor networks. The connection column is a navigation aid, not a claim that every firm has a city office or accepts every local company. On small screens, scroll the table sideways to compare all columns.
| Investor or network | Connection | Initial-stage distinction | Company focus |
|---|---|---|---|
| IAG Capital Partners | Local connection: Charleston-based | Seed through Series D | Venture companies; confirm sector fit |
| Alerion Ventures | Local connection: Charleston; Southeast preference | After proof of concept and initial revenue | B2B software, tech-enabled services and selected healthcare/efficiency |
| Good Growth Capital | Local connection: Charleston-linked; broader science opportunities | Early stage | Life sciences, data sciences and green technology |
| VentureSouth | State / regional: Southeastern U.S. | Early stage, seed and Series A criteria | Scalable ventures with customer demand |
| SC Launch, Inc. | State / regional: South Carolina; SCRA membership and economic-impact conditions | Seed through later rounds, strategy-dependent | High-growth technology |
| IDEA Fund Partners | State / regional: Carolinas-based; underserved markets | Early company stage; confirm vehicle | Innovative technology |
| Oval Park Capital | State / regional: Overlooked U.S. ecosystems | Seed | IP-driven hardtech and industrial technology |
| Cofounders Capital | State / regional: Southeastern U.S. | Seed; first institutional capital | B2B software |
| Hatteras Venture Partners | State / regional: Southeast-based; wider specialist investing | Stage depends on dedicated strategy | Biotech, medtech and healthtech |
| Harbert Growth Partners | State / regional: Mid-Atlantic, Southeast and Southwest | Emerging growth | Enterprise software, cyber, fintech and healthcare IT |
| Overline | Wider mandate: Atlanta and Southeast | Inception through seed | Early high-growth companies |
| Tech Square Ventures | Wider mandate: Atlanta-linked; wider enterprise opportunities | Primarily seed; selected pre-seed and Series A | Enterprise and marketplace technology |
| BIP Ventures | Wider mandate: Atlanta-based; wider qualifying companies | High-growth venture stage; confirm vehicle | Technology companies |
| Circadian Ventures | Wider mandate: Southeast-linked; multi-state portfolio | Venture stage; confirm entry round | Technology across several sectors |
| Valor Ventures | Wider mandate: Southern U.S. | First institutional rounds | B2B software |
| Capacity Capital | Wider mandate: Bias toward Southeast U.S. | Early commercial stage with sustained revenue | Capital-efficient high-growth companies |
Which Charleston investors can lead a round?
Use current published behavior rather than assuming the largest name will lead. IAG describes leading from seed through Series D; Cofounders and Valor describe leading early software rounds. Those statements are useful research filters, not commitments to your round. Ask about current vehicle capacity and the role needed after establishing company fit.
What does Alerion’s investment focus rule out?
Alerion’s current page excludes consumer-facing businesses, drug discovery, medical devices, energy production and project finance. It prefers capital-efficient companies with initial market and revenue traction. That can make it a strong research candidate for a qualifying software company and a poor one for a device startup. Use the restriction to choose a better conversation, not to rewrite your company to fit a fund.
16 investors and networks to research
1. IAG Capital Partners
Venture capital firm. IAG is based in Charleston and describes leading rounds from seed through Series D. That range makes the required round role an important opening question. Review current portfolio and team expertise before assuming that all local sectors fit the same investment strategy.
Public approach: Use the official Contact page. Official IAG Capital Partners information.
2. Alerion Ventures
Evergreen venture firm. Alerion favors capital-efficient companies with initial market and revenue traction. Its current exclusions include consumer businesses, drug discovery, medical devices and project finance. Use that specificity to decide quickly whether to approach or move to another capital lane.
Public approach: Use the official Focus and Contact sections. Official Alerion Ventures information.
3. Good Growth Capital
Venture capital firm. Good Growth specializes in early science and technology, including life sciences, data sciences and green technology. Its technical breadth can suit research-heavy companies, but the scientific and commercial case still needs to be clear. Match your development milestone to a relevant partner.
Public approach: Use the official investment areas and contact route. Official Good Growth Capital information.
4. VentureSouth
Angel-investor platform. VentureSouth is a regional early-stage investment network. Its criteria emphasize Southeast location, customer demand and capital-efficient scale. Count the platform once, including relevant local groups, rather than adding every chapter as an independent investor.
Public approach: Use the official How to Pitch information. Official VentureSouth information. Additional official criteria or platform context.
5. SC Launch, Inc.
Public-purpose venture investor. SC Launch is SCRA’s investment affiliate, providing convertible loans and equity to qualifying program companies. Its capital is distinct from SCRA grants. Review membership, economic impact, prior support and matching-round expectations before entering investment diligence.
Public approach: Use the official Criteria and Eligibility page. Official SC Launch, Inc. information. Additional official criteria or platform context.
6. IDEA Fund Partners
Venture capital firm. IDEA Fund Partners emphasizes innovation and founders outside traditional venture patterns. Its Carolinas presence provides a regional research path, not automatic eligibility. Bring a specific explanation of the technology, business model and why the company can grow from its chosen market.
Public approach: Use the official Founders: Pitch Us route. Official IDEA Fund Partners information.
7. Oval Park Capital
Venture capital firm. Oval Park backs seed-stage hardtech commercializing physical and industrial technologies. Its thesis values defensible IP in mission-critical industries. A founder should explain the engineering breakthrough and how the next deployment or production milestone reduces commercial risk.
Public approach: Use the official Focus and Contact information. Official Oval Park Capital information.
8. Cofounders Capital
Venture capital firm. Cofounders Capital explicitly leads seed B2B software investments across the Southeast. It is a useful route when you need both a first institutional partner and hands-on software-company experience. Show the buyer, use case and evidence that the product solves a valuable problem.
Public approach: Review the official strategy and use the published founder or team contact route. Official Cofounders Capital information.
9. Hatteras Venture Partners
Venture capital firm. Hatteras invests across healthcare with dedicated strategies. A founder should identify the relevant fund and development stage rather than assume one entry criterion covers therapeutics, devices and health software. Lead with the scientific, clinical or operating evidence appropriate to the product.
Public approach: Use the official dedicated-funds and contact information. Official Hatteras Venture Partners information.
10. Harbert Growth Partners
Venture capital firm. Harbert Growth Partners targets emerging growth-stage technology businesses in several U.S. regions. Its criteria emphasize scalable platforms, recurring revenue and experienced management. It belongs in a growth shortlist, not an undifferentiated list of idea-stage investors.
Public approach: Use Harbert Growth Equity strategy and team contacts. Official Harbert Growth Partners information.
11. Overline
Venture capital firm. Overline explicitly invests from inception through seed across the Southeast. That makes it a plausible early institutional lane before a founder has a polished growth story. Be precise about the problem, what has been learned and the next evidence-building milestone.
Public approach: Use the official Share Your Pitch page. Official Overline information.
12. Tech Square Ventures
Venture capital firm. Tech Square invests in enterprise and marketplace technology, primarily at seed. Its current approach can be relevant to companies selling into established businesses. Explain adoption, buyer incentives and the evidence behind a repeatable commercial opportunity.
Public approach: Use the official stage/focus and contact pages. Official Tech Square Ventures information.
13. BIP Ventures
Venture capital firm. BIP Ventures combines capital with operating support for high-growth companies. Research the current team and specific founder route, rather than treating an older platform name as another investor. Explain the competitive advantage and current growth milestone the investment would support.
Public approach: Use the official I’m a Founder route. Official BIP Ventures information.
14. Circadian Ventures
Venture capital firm. Circadian’s current portfolio spans software and technology businesses in multiple markets, including the Southeast. Use that as discovery context, then establish the current entry-stage and thesis fit. A nearby portfolio company alone does not establish an unrestricted regional mandate.
Public approach: Use the official Entrepreneurs and Contact pages. Official Circadian Ventures information.
15. Valor Ventures
Venture capital firm. Valor leads first rounds in B2B software across the South. This is a more precise match than a generic regional VC description. Show a real business customer, a compelling workflow and why your team has an advantage in serving the market.
Public approach: Use Share a Startup With Valor on the official site. Official Valor Ventures information.
16. Capacity Capital
Venture capital firm. Capacity looks for cash-efficient growth, sustained revenue and a line of sight to break-even. Its published fit is different from long-cycle R&D or winner-take-all spending. Explain the business inflection and why risk capital is the appropriate tool.
Public approach: Use the official Apply for Funding route. Official Capacity Capital information.
A Charleston health company distinguishes devices from software
Fictional worked example. A fictional startup has software that improves a provider’s operational workflow and two paying customers. It has no regulated device or drug-development program. The seed round would fund a repeatable implementation and sales motion.
| Candidate lane | Next action | Why it changes the decision |
|---|---|---|
| Alerion / Cofounders / Valor | Research B2B software and revenue-stage fit | The product and evidence align with a specific lane. |
| Good Growth / IAG | Match the relevant team, stage and investment role | A Charleston connection supports research, not automatic eligibility. |
| Device or drug-specific capital | Do not prioritize without an actual scientific-development need | Healthcare terminology alone does not define the financing category. |
Keep the round tied to a concrete milestone. The round-size planning worksheet can help organize assumptions before you commit to an outreach target.
Build your Charleston, South Carolina investor-fit worksheet
Use one card per investment organization and strategy. The worksheet works in a document, spreadsheet or Finta research notes. Keep verified facts, assumptions and unanswered questions distinct.
INVESTOR FIT CARD: CHARLESTON, SOUTH CAROLINA
Company and next funding milestone: [authorized company facts]
Product classification: [software / device / therapeutic / physical technology]
Traction: [customer evidence and revenue quality]
Lead-round need: [published behavior versus directly confirmed interest]
Investor family and specific vehicle: [current name; avoid duplicates]
Official stage, sector and geography: [source URL and research date]
Fit evidence: [what actually matches]
Mismatch or open question: [what remains unresolved]
Investor role: [lead / participant / unknown; source or direct confirmation]
Approach route: [public founder route / team contact / permitted introduction]
Relationship context: [known person; permission to ask; no assumed introduction]
Owner, next action and follow-up date: [person; task; date]Bring your shortlist into Finta to connect investor research, relationship context, conversations and follow-up. Aurora can help organize the context and prepare next steps for your review. You stay in control of the approach and the information shared.
Review the shortlist with Aurora, Claude or Codex
Use the public sources and company information you are authorized to share. Check the output against those sources before acting.
Help me build an evidence-backed investor shortlist for a Charleston, South Carolina startup.
Company, location, current evidence and next funding milestone: [authorized facts]
Candidates and official sources: [names, URLs and dates]
Separate local offices, regional requirements and wider investment eligibility.
Check the current investor family, vehicle, entry stage, sector and public founder route.
Distinguish equity investors, angel networks, investing accelerators, grants and service providers.
Do not infer current eligibility from a historic portfolio investment or a nearby office.
Return a table: investor, fit evidence, mismatch, unknown, next question and action owner.
Choose a small first research wave and explain exclusions.
Keep missing or contradictory facts as unknown rather than inventing answers.
Do not contact anyone, submit applications or share confidential information.Keep the broader raise connected with the pre-seed guide, Seed Fundraising Comprehensive Guide and investor-prospecting workflow. For a national starting point, see the U.S. venture-capital and angel-investor guide.
Methodology and research date
By Finta Editorial Team. Official investor and institutional materials reviewed November 13, 2026. This guide includes 16 investor families or clearly identified networks: 3 local connections, 7 state or regional routes and 6 wider options. A local connection can be a university route or regional network group, not necessarily a standalone fund office.
Names, investment roles and published theses were checked against the official sources linked in each profile. Related managers, rebrands and chapters are grouped conservatively. Unspecified entry stages, geography and current intake are left as questions, not invented criteria. A published strategy is not a guarantee of available capital or a funding outcome. The cover is an editorial ecosystem illustration, not a map of investor offices or actual financing flows.
Not counted or kept separate:
- Charleston Angel Partners and VentureSouth-related network entries are not counted twice.
- Real-estate and buyout strategies are not relabeled as early startup venture capital.
General information, not personalized financial, legal or tax advice. Confirm investment terms and company eligibility with the provider and appropriate advisers.